Global Molecular Diagnosis and Therapy Market Research Report 2023

Report ID: 1894328 | Published Date: Oct 2024 | No. of Page: 92 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 PCR
        1.2.3 DNA Sequencing
        1.2.4 NGS
    1.3 Market by Application
        1.3.1 Global Molecular Diagnosis and Therapy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Diagnostic Laboratories
        1.3.3 Research & Academic Laboratories
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Molecular Diagnosis and Therapy Market Perspective (2017-2028)
    2.2 Molecular Diagnosis and Therapy Growth Trends by Region
        2.2.1 Molecular Diagnosis and Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Molecular Diagnosis and Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Molecular Diagnosis and Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Molecular Diagnosis and Therapy Market Dynamics
        2.3.1 Molecular Diagnosis and Therapy Industry Trends
        2.3.2 Molecular Diagnosis and Therapy Market Drivers
        2.3.3 Molecular Diagnosis and Therapy Market Challenges
        2.3.4 Molecular Diagnosis and Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Molecular Diagnosis and Therapy Players by Revenue
        3.1.1 Global Top Molecular Diagnosis and Therapy Players by Revenue (2017-2022)
        3.1.2 Global Molecular Diagnosis and Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Molecular Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Molecular Diagnosis and Therapy Revenue
    3.4 Global Molecular Diagnosis and Therapy Market Concentration Ratio
        3.4.1 Global Molecular Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis and Therapy Revenue in 2021
    3.5 Molecular Diagnosis and Therapy Key Players Head office and Area Served
    3.6 Key Players Molecular Diagnosis and Therapy Product Solution and Service
    3.7 Date of Enter into Molecular Diagnosis and Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnosis and Therapy Breakdown Data by Type
    4.1 Global Molecular Diagnosis and Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2023-2028)
5 Molecular Diagnosis and Therapy Breakdown Data by Application
    5.1 Global Molecular Diagnosis and Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Molecular Diagnosis and Therapy Market Size (2017-2028)
    6.2 North America Molecular Diagnosis and Therapy Market Size by Country (2017-2022)
    6.3 North America Molecular Diagnosis and Therapy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Molecular Diagnosis and Therapy Market Size (2017-2028)
    7.2 Europe Molecular Diagnosis and Therapy Market Size by Country (2017-2022)
    7.3 Europe Molecular Diagnosis and Therapy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Molecular Diagnosis and Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Molecular Diagnosis and Therapy Market Size (2017-2028)
    9.2 Latin America Molecular Diagnosis and Therapy Market Size by Country (2017-2022)
    9.3 Latin America Molecular Diagnosis and Therapy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Molecular Diagnosis and Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Detail
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Introduction
        11.1.4 Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Development
    11.2 Agilent Technologies
        11.2.1 Agilent Technologies Company Detail
        11.2.2 Agilent Technologies Business Overview
        11.2.3 Agilent Technologies Molecular Diagnosis and Therapy Introduction
        11.2.4 Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.2.5 Agilent Technologies Recent Development
    11.3 Becton, Dickinson and Company
        11.3.1 Becton, Dickinson and Company Company Detail
        11.3.2 Becton, Dickinson and Company Business Overview
        11.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Introduction
        11.3.4 Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.3.5 Becton, Dickinson and Company Recent Development
    11.4 Biomérieux Sa
        11.4.1 Biomérieux Sa Company Detail
        11.4.2 Biomérieux Sa Business Overview
        11.4.3 Biomérieux Sa Molecular Diagnosis and Therapy Introduction
        11.4.4 Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.4.5 Biomérieux Sa Recent Development
    11.5 Danaher Corporation
        11.5.1 Danaher Corporation Company Detail
        11.5.2 Danaher Corporation Business Overview
        11.5.3 Danaher Corporation Molecular Diagnosis and Therapy Introduction
        11.5.4 Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.5.5 Danaher Corporation Recent Development
    11.6 Diasorin
        11.6.1 Diasorin Company Detail
        11.6.2 Diasorin Business Overview
        11.6.3 Diasorin Molecular Diagnosis and Therapy Introduction
        11.6.4 Diasorin Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.6.5 Diasorin Recent Development
    11.7 Grifols
        11.7.1 Grifols Company Detail
        11.7.2 Grifols Business Overview
        11.7.3 Grifols Molecular Diagnosis and Therapy Introduction
        11.7.4 Grifols Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.7.5 Grifols Recent Development
    11.8 Hologic
        11.8.1 Hologic Company Detail
        11.8.2 Hologic Business Overview
        11.8.3 Hologic Molecular Diagnosis and Therapy Introduction
        11.8.4 Hologic Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.8.5 Hologic Recent Development
    11.9 Illumina
        11.9.1 Illumina Company Detail
        11.9.2 Illumina Business Overview
        11.9.3 Illumina Molecular Diagnosis and Therapy Introduction
        11.9.4 Illumina Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.9.5 Illumina Recent Development
    11.10 Qiagen
        11.10.1 Qiagen Company Detail
        11.10.2 Qiagen Business Overview
        11.10.3 Qiagen Molecular Diagnosis and Therapy Introduction
        11.10.4 Qiagen Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.10.5 Qiagen Recent Development
    11.11 Roche Diagnostics
        11.11.1 Roche Diagnostics Company Detail
        11.11.2 Roche Diagnostics Business Overview
        11.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Introduction
        11.11.4 Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.11.5 Roche Diagnostics Recent Development
    11.12 Siemens AG
        11.12.1 Siemens AG Company Detail
        11.12.2 Siemens AG Business Overview
        11.12.3 Siemens AG Molecular Diagnosis and Therapy Introduction
        11.12.4 Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.12.5 Siemens AG Recent Development
    11.13 Thermo Fisher Scientific
        11.13.1 Thermo Fisher Scientific Company Detail
        11.13.2 Thermo Fisher Scientific Business Overview
        11.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Introduction
        11.13.4 Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2017-2022)
        11.13.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of PCR
    Table 3. Key Players of DNA Sequencing
    Table 4. Key Players of NGS
    Table 5. Global Molecular Diagnosis and Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Molecular Diagnosis and Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Molecular Diagnosis and Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Molecular Diagnosis and Therapy Market Share by Region (2017-2022)
    Table 9. Global Molecular Diagnosis and Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Molecular Diagnosis and Therapy Market Share by Region (2023-2028)
    Table 11. Molecular Diagnosis and Therapy Market Trends
    Table 12. Molecular Diagnosis and Therapy Market Drivers
    Table 13. Molecular Diagnosis and Therapy Market Challenges
    Table 14. Molecular Diagnosis and Therapy Market Restraints
    Table 15. Global Molecular Diagnosis and Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Molecular Diagnosis and Therapy Market Share by Players (2017-2022)
    Table 17. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis and Therapy as of 2021)
    Table 18. Ranking of Global Top Molecular Diagnosis and Therapy Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Molecular Diagnosis and Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Molecular Diagnosis and Therapy Product Solution and Service
    Table 22. Date of Enter into Molecular Diagnosis and Therapy Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Molecular Diagnosis and Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2017-2022)
    Table 26. Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2023-2028)
    Table 28. Global Molecular Diagnosis and Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Molecular Diagnosis and Therapy Revenue Market Share by Application (2017-2022)
    Table 30. Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Molecular Diagnosis and Therapy Revenue Market Share by Application (2023-2028)
    Table 32. North America Molecular Diagnosis and Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Molecular Diagnosis and Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Molecular Diagnosis and Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Molecular Diagnosis and Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Molecular Diagnosis and Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Molecular Diagnosis and Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Abbott Laboratories Company Detail
    Table 43. Abbott Laboratories Business Overview
    Table 44. Abbott Laboratories Molecular Diagnosis and Therapy Product
    Table 45. Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 46. Abbott Laboratories Recent Development
    Table 47. Agilent Technologies Company Detail
    Table 48. Agilent Technologies Business Overview
    Table 49. Agilent Technologies Molecular Diagnosis and Therapy Product
    Table 50. Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 51. Agilent Technologies Recent Development
    Table 52. Becton, Dickinson and Company Company Detail
    Table 53. Becton, Dickinson and Company Business Overview
    Table 54. Becton, Dickinson and Company Molecular Diagnosis and Therapy Product
    Table 55. Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 56. Becton, Dickinson and Company Recent Development
    Table 57. Biomérieux Sa Company Detail
    Table 58. Biomérieux Sa Business Overview
    Table 59. Biomérieux Sa Molecular Diagnosis and Therapy Product
    Table 60. Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 61. Biomérieux Sa Recent Development
    Table 62. Danaher Corporation Company Detail
    Table 63. Danaher Corporation Business Overview
    Table 64. Danaher Corporation Molecular Diagnosis and Therapy Product
    Table 65. Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 66. Danaher Corporation Recent Development
    Table 67. Diasorin Company Detail
    Table 68. Diasorin Business Overview
    Table 69. Diasorin Molecular Diagnosis and Therapy Product
    Table 70. Diasorin Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 71. Diasorin Recent Development
    Table 72. Grifols Company Detail
    Table 73. Grifols Business Overview
    Table 74. Grifols Molecular Diagnosis and Therapy Product
    Table 75. Grifols Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 76. Grifols Recent Development
    Table 77. Hologic Company Detail
    Table 78. Hologic Business Overview
    Table 79. Hologic Molecular Diagnosis and Therapy Product
    Table 80. Hologic Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 81. Hologic Recent Development
    Table 82. Illumina Company Detail
    Table 83. Illumina Business Overview
    Table 84. Illumina Molecular Diagnosis and Therapy Product
    Table 85. Illumina Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 86. Illumina Recent Development
    Table 87. Qiagen Company Detail
    Table 88. Qiagen Business Overview
    Table 89. Qiagen Molecular Diagnosis and Therapy Product
    Table 90. Qiagen Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 91. Qiagen Recent Development
    Table 92. Roche Diagnostics Company Detail
    Table 93. Roche Diagnostics Business Overview
    Table 94. Roche Diagnostics Molecular Diagnosis and TherapyProduct
    Table 95. Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 96. Roche Diagnostics Recent Development
    Table 97. Siemens AG Company Detail
    Table 98. Siemens AG Business Overview
    Table 99. Siemens AG Molecular Diagnosis and TherapyProduct
    Table 100. Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 101. Siemens AG Recent Development
    Table 102. Thermo Fisher Scientific Company Detail
    Table 103. Thermo Fisher Scientific Business Overview
    Table 104. Thermo Fisher Scientific Molecular Diagnosis and TherapyProduct
    Table 105. Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million)
    Table 106. Thermo Fisher Scientific Recent Development
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Molecular Diagnosis and Therapy Market Share by Type: 2021 VS 2028
    Figure 2. PCR Features
    Figure 3. DNA Sequencing Features
    Figure 4. NGS Features
    Figure 5. Global Molecular Diagnosis and Therapy Market Share by Application in 2021 & 2028
    Figure 6. Diagnostic Laboratories Case Studies
    Figure 7. Research & Academic Laboratories Case Studies
    Figure 8. Molecular Diagnosis and Therapy Report Years Considered
    Figure 9. Global Molecular Diagnosis and Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Molecular Diagnosis and Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Molecular Diagnosis and Therapy Market Share by Region: 2021 VS 2028
    Figure 12. Global Molecular Diagnosis and Therapy Market Share by Players in 2021
    Figure 13. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis and Therapy as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Molecular Diagnosis and Therapy Revenue in 2021
    Figure 15. North America Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Molecular Diagnosis and Therapy Market Share by Country (2017-2028)
    Figure 17. United States Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Molecular Diagnosis and Therapy Market Share by Country (2017-2028)
    Figure 21. Germany Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Molecular Diagnosis and Therapy Market Share by Region (2017-2028)
    Figure 29. China Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Molecular Diagnosis and Therapy Market Share by Country (2017-2028)
    Figure 37. Mexico Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Molecular Diagnosis and Therapy Market Share by Country (2017-2028)
    Figure 41. Turkey Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Abbott Laboratories Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 44. Agilent Technologies Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 45. Becton, Dickinson and Company Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 46. Biomérieux Sa Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 47. Danaher Corporation Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 48. Diasorin Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 49. Grifols Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 50. Hologic Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 51. Illumina Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 52. Qiagen Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 53. Roche Diagnostics Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 54. Siemens AG Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Biomérieux Sa
Danaher Corporation
Diasorin
Grifols
Hologic
Illumina
Qiagen
Roche Diagnostics
Siemens AG
Thermo Fisher Scientific
Frequently Asked Questions
Molecular Diagnosis and Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Molecular Diagnosis and Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Molecular Diagnosis and Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports